Skip to main content

Table 3 Outcome measures at baseline by timing of application

From: Evaluation of the impact of a chronic disease scheme reimbursing medical costs of patients with diabetes in Anhui province, China: a follow-up study

 

Timing of CDS application

 

Outcome measure

Not by baseline

≤12 months before baseline

>12 months before baseline

p=0.03

HbA1c: mean (SD)

8.03 (1.99)

7.69 (1.82)

8.10 (1.87)

 

Seen at county or higher level hospital: %

53.6

81.6

65.9

0.00

Number of types of test: mean (SD)

1.28 (0.74)

1.62 (0.81)

1.42 (0.77)

0.00

Number of hospital visits: mean (SD)

2.94 (3.80)

5.48 (5.71)

4.93 (4.34)

0.00

SF-12 physical: mean (SD)

34.4 (8.9)

33.8 (8.1)

33.0 (7.9)

0.07

SF-12 mental: mean (SD)

39.6 (11.1)

37.9 (11.6)

37.7 (10.9)

0.03

EQ-5D health scale: mean (SD)

57.6 (14.4)

58.4 (14.3)

56.4 (14.3)

0.27

Cost of treatment ‘greatly burdensome’ %

38.2

48.6

57.1

0.00

N

524

245

287

  1. (N = 1056)